| No. 25-348 |
|
| Title: |
AstraZeneca Pharmaceuticals LP, et al., Petitioners v. Robert F. Kennedy, Secretary of Health and Human Services, et al. |
| Docketed: | September 24, 2025 |
| Linked with: | 25A115 |
| Lower Ct: | United States Court of Appeals for the Third Circuit |
| Case Numbers: | (24-1819) |
| Decision Date: | May 8, 2025 |
| Jul 24 2025 | Application (25A115) to extend the time to file a petition for a writ of certiorari from August 6, 2025 to September 20, 2025, submitted to Justice Alito. Main Document Lower Court Orders/Opinions Proof of Service |
| Jul 28 2025 | Application (25A115) granted by Justice Alito extending the time to file until September 20, 2025. |
| Sep 19 2025 | Petition for a writ of certiorari filed. (Response due October 24, 2025) Petition Appendix Certificate of Word Count Proof of Service |
| Sep 26 2025 | Motion to extend the time to file a response from October 24, 2025 to November 24, 2025, submitted to The Clerk. Main Document |
| Sep 29 2025 | Motion to extend the time to file a response is granted and the time is extended to and including November 24, 2025. |
| Nov 20 2025 | Motion to extend the time to file a response from November 24, 2025 to December 24, 2025, submitted to The Clerk. Main Document |
| Nov 21 2025 | Motion to extend the time to file a response is granted and the time is further extended to and including December 24, 2025. |
| Dec 18 2025 | Motion to extend the time to file a response from December 24, 2025 to January 2, 2026, submitted to The Clerk. Main Document |
| Dec 19 2025 | Motion to extend the time to file a response is granted and the time is further extended to and including January 2, 2026. |
| Jan 02 2026 | Brief of respondents Secretary of Health and Human Services, Robert F. Kennedy, et al. in opposition filed. Main Document Proof of Service |
| Jan 02 2026 | Waiver of the 14-day waiting period for the distribution of the petition pursuant to Rule 15.5 filed by petitioner. Main Document |
| Jan 07 2026 | DISTRIBUTED for Conference of 1/23/2026. |
| Jan 07 2026 | Reply of AstraZeneca Pharmaceuticals LP, et al. submitted. Main Document Certificate of Word Count Proof of Service |